Literature DB >> 17143772

Hyaluronic acid hydrogel immobilized with RGD peptides for brain tissue engineering.

F Z Cui1, W M Tian, S P Hou, Q Y Xu, I-S Lee.   

Abstract

In this paper, hyaluronic acid hydrogels with open porous structure have been developed for scaffold of brain tissue engineering. A short peptide sequence of arginine-glycine-aspartic acid (RGD) was immobilized on the backbone of the hydrogels. Both unmodified hydrogels and those modified with RGD were implanted into the defects of cortex in rats and evaluated for their ability to improve tissue reconstruction. After 6 and 12 weeks, sections of brains were processed for DAB and Glees staining. They were also labeled with GFAP and ED1 antibodies, and observed under the SEM for ultrastructral examination. After implanting into the lesion of cortex, the porous hydrogels functioned as a scaffold to support cells infiltration and angiogenesis, simultaneously inhibiting the formation of glial scar. In addition, HA hydrogels modified with RGD were able to promote neurites extension. Our experiments showed that the hyaluronic acid-RGD hydrogel provided a structural, three-dimensional continuity across the defect and favoured reorganization of local wound-repair cells, angiogenesis and axonal growth into the hydrogel scaffold, while there was little evidence of axons regeneration in unmodified hydrogel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17143772     DOI: 10.1007/s10856-006-0615-7

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  54 in total

Review 1.  Facilitatory and inhibitory effects of glial cells and extracellular matrix in axonal regeneration.

Authors:  S Carbonetto
Journal:  Curr Opin Neurobiol       Date:  1991-10       Impact factor: 6.627

Review 2.  Neural cell contact and axonal growth.

Authors:  F G Rathjen
Journal:  Curr Opin Cell Biol       Date:  1991-12       Impact factor: 8.382

Review 3.  The structure and function of hyaluronan: An overview.

Authors:  T C Laurent; U B Laurent; J R Fraser
Journal:  Immunol Cell Biol       Date:  1996-04       Impact factor: 5.126

4.  Astrocytes block axonal regeneration in mammals by activating the physiological stop pathway.

Authors:  F J Liuzzi; R J Lasek
Journal:  Science       Date:  1987-08-07       Impact factor: 47.728

5.  Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro.

Authors:  R Montesano; S Kumar; L Orci; M S Pepper
Journal:  Lab Invest       Date:  1996-08       Impact factor: 5.662

6.  Neural tissue engineering: from polymer to biohybrid organs.

Authors:  S Woerly; G W Plant; A R Harvey
Journal:  Biomaterials       Date:  1996-02       Impact factor: 12.479

7.  Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes.

Authors:  R A Gadient; K C Cron; U Otten
Journal:  Neurosci Lett       Date:  1990-09-18       Impact factor: 3.046

8.  Dibutyryl cAMP, interleukin-1 beta, and macrophage conditioned medium enhance the ability of astrocytes to promote neurite growth.

Authors:  C Miller; O Tsatas; S David
Journal:  J Neurosci Res       Date:  1994-05-01       Impact factor: 4.164

9.  Macrophage interactions with laminin: PMA selectively induces the adherence and spreading of mouse macrophages on a laminin substratum.

Authors:  A M Mercurio; L M Shaw
Journal:  J Cell Biol       Date:  1988-11       Impact factor: 10.539

10.  Intracerebral implantation of hydrogel-coupled adhesion peptides: tissue reaction.

Authors:  S Woerly; G Laroche; R Marchand; J Pato; V Subr; K Ulbrich
Journal:  J Neural Transplant Plast       Date:  1995
View more
  22 in total

1.  Maleimide-thiol coupling of a bioactive peptide to an elastin-like protein polymer.

Authors:  Swathi Ravi; Venkata R Krishnamurthy; Jeffrey M Caves; Carolyn A Haller; Elliot L Chaikof
Journal:  Acta Biomater       Date:  2011-10-25       Impact factor: 8.947

Review 2.  Biomaterials for spinal cord repair.

Authors:  Agnes E Haggerty; Martin Oudega
Journal:  Neurosci Bull       Date:  2013-07-18       Impact factor: 5.203

Review 3.  Biomaterial design strategies for the treatment of spinal cord injuries.

Authors:  Karin S Straley; Cheryl Wong Po Foo; Sarah C Heilshorn
Journal:  J Neurotrauma       Date:  2010-01       Impact factor: 5.269

Review 4.  Biomaterials for the central nervous system.

Authors:  Yinghui Zhong; Ravi V Bellamkonda
Journal:  J R Soc Interface       Date:  2008-09-06       Impact factor: 4.118

Review 5.  Biomaterial selection for tooth regeneration.

Authors:  Zhenglin Yuan; Hemin Nie; Shuang Wang; Chang Hun Lee; Ang Li; Susan Y Fu; Hong Zhou; Lili Chen; Jeremy J Mao
Journal:  Tissue Eng Part B Rev       Date:  2011-10       Impact factor: 6.389

6.  Decellularized porcine brain matrix for cell culture and tissue engineering scaffolds.

Authors:  Jessica A DeQuach; Shauna H Yuan; Lawrence S B Goldstein; Karen L Christman
Journal:  Tissue Eng Part A       Date:  2011-10-17       Impact factor: 3.845

Review 7.  Mesenchymal stem cells engineered for cancer therapy.

Authors:  Khalid Shah
Journal:  Adv Drug Deliv Rev       Date:  2011-06-29       Impact factor: 15.470

8.  Collagen type I hydrogel allows migration, proliferation, and osteogenic differentiation of rat bone marrow stromal cells.

Authors:  Eric Hesse; Theresa E Hefferan; James E Tarara; Carl Haasper; Rupert Meller; Christian Krettek; Lichun Lu; Michael J Yaszemski
Journal:  J Biomed Mater Res A       Date:  2010-08       Impact factor: 4.396

9.  Hyaluronic acid-based scaffold for central neural tissue engineering.

Authors:  Xiumei Wang; Jin He; Ying Wang; Fu-Zhai Cui
Journal:  Interface Focus       Date:  2012-03-21       Impact factor: 3.906

10.  Enzymatically crosslinked silk-hyaluronic acid hydrogels.

Authors:  Nicole R Raia; Benjamin P Partlow; Meghan McGill; Erica Palma Kimmerling; Chiara E Ghezzi; David L Kaplan
Journal:  Biomaterials       Date:  2017-03-27       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.